PROSPECTIVE MULTICENTER EVALUATION OF PCA3 AND TMPRSS2-ERG GENE FUSIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR PROSTATE CANCER

被引：0
|
作者：
Leyten, Gisele
Hessels, Daphne
Cornel, Erik
de Reyke, Theo
Vergunst, Henk
Kil, Paul
Knipscheer, Ben
Jannink, Sander
Smit, Frank
de Jong, Hans
van Oort, Inge
Mulders, Peter
Schalken, Jack
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.2272
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2104
引用
收藏
页码：E848 / E849
页数：2
相关论文
共 50 条
  • [1] Prospective Multicenter Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Biomarkers for Prostate Cancer
    Leyten, G.
    Hessels, D.
    Cornel, E.
    de Reyke, T.
    Vergunst, H.
    Kil, P.
    Knipscheer, B.
    van Oort, I
    Mulders, P.
    Schalken, J.
    UROLOGY, 2012, 80 (03) : S102 - S102
  • [2] PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer
    Yang, Zheng
    Yu, Lu
    Wang, Zhe
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (01) : 65 - 71
  • [3] Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
    Leyten, Gisele H. J. M.
    Hessels, Daphne
    Jannink, Sander A.
    Smit, Frank P.
    de Jong, Hans
    Cornel, Erik B.
    de Reijke, Theo M.
    Vergunst, Henk
    Kil, Paul
    Knipscheer, Ben C.
    van Oort, Inge M.
    Mulders, Peter F. A.
    Hulsbergen-van de Kaa, Christina A.
    Schalken, Jack A.
    EUROPEAN UROLOGY, 2014, 65 (03) : 534 - 542
  • [4] PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer
    Zheng Yang
    Lu Yu
    Zhe Wang
    ChineseJournalofCancerResearch, 2016, 28 (01) : 65 - 71
  • [5] Biomarkers PCA3 and TMPRSS2-ERG: better together
    Nature Reviews Urology, 2014, 11 (3) : 129 - 129
  • [6] PCA3 AND TMPRSS2-ERG: MOLECULAR URINE TESTS IN PROSTATE CANCER
    Rittenhouse, H.
    TUMOR BIOLOGY, 2010, 31 : S27 - S28
  • [7] Prospective multicenter evaluation of PCA3+TMPRSS2-ERG as a diagnostic and prognostic marker panel for prostate cancer
    Leyten, G. H. J. M.
    Hessels, D.
    Cornel, E. B.
    De Reijke, T. M.
    Vergunst, H.
    Kil, P.
    Knipscheer, B. C.
    Van Oort, I. M.
    Mulders, P. F. A.
    Schalken, J. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E913 - U920
  • [8] Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization- a correlative study with urine PCA3 and TMPRSS2-ERG
    Warrick, Joshua I.
    Tomlins, Scott A.
    Carskadon, Shannon L.
    Young, Allison M.
    Siddiqui, Javed
    Wei, John T.
    Chinnaiyan, Arul M.
    Kunju, Lakshmi P.
    Palanisamy, Nallasivam
    MODERN PATHOLOGY, 2014, 27 (04) : 609 - 620
  • [9] PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
    Warli, Syah Mirsya
    Warli, Muhammad Haritsyah
    Prapiska, Fauriski Febrian
    RESEARCH AND REPORTS IN UROLOGY, 2023, 15 : 149 - 155
  • [10] Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer
    Kulda, Vlastimil
    Topolcan, Ondrej
    Kucera, Radek
    Kripnerova, Michaela
    Srbecka, Kristyna
    Hora, Milan
    Hes, Ondrej
    Klecka, Jiri
    Babuska, Vaclav
    Rousarova, Milena
    Benson, Veronika
    Pesta, Martin
    ANTICANCER RESEARCH, 2016, 36 (09) : 4787 - 4793
12345